105 related articles for article (PubMed ID: 1319891)
1. [Value of serum glycosidase spectrum in the diagnosis of hepatocellular carcinoma].
Zhang SM
Zhonghua Zhong Liu Za Zhi; 1992 Mar; 14(2):143-6. PubMed ID: 1319891
[TBL] [Abstract][Full Text] [Related]
2. Activities of serum enzymes in patients with viral hepatitis B, posthepatitic cirrhosis and hepatocellular carcinoma.
Zheng T; Ren ZY
Chin Med J (Engl); 1990 Sep; 103(9):729-34. PubMed ID: 2174763
[TBL] [Abstract][Full Text] [Related]
3. Rapid kinetic rate assay of the serum alpha-L-fucosidase in patients with hepatocellular carcinoma by using a novel substrate.
Wang JJ; Cao EH
Clin Chim Acta; 2004 Sep; 347(1-2):103-9. PubMed ID: 15313147
[TBL] [Abstract][Full Text] [Related]
4. Usefulness of alpha-fetoprotein in the diagnosis of hepatocellular carcinoma.
Soresi M; Magliarisi C; Campagna P; Leto G; Bonfissuto G; Riili A; Carroccio A; Sesti R; Tripi S; Montalto G
Anticancer Res; 2003; 23(2C):1747-53. PubMed ID: 12820452
[TBL] [Abstract][Full Text] [Related]
5. Alpha-fetoprotein reaction to Pisum sativum agglutinin in differentiation of benign liver diseases from hepatocellular carcinoma.
Yin ZF; Tu ZX; Cui ZF; Wu MC
Chin Med J (Engl); 1993 Aug; 106(8):615-8. PubMed ID: 7693403
[TBL] [Abstract][Full Text] [Related]
6. [A preliminary study on serum alpha-L-fucosidase assay in the diagnosis of hepatocellular carcinoma].
Shen W; Shen DM
Zhonghua Nei Ke Za Zhi; 1989 Jul; 28(7):397-9, 442-3. PubMed ID: 2480210
[TBL] [Abstract][Full Text] [Related]
7. [Value of alpha 1-fetoprotein (AFP) determination with an ultramicro-ELISA immunoassay in chronic liver diseases with special reference to hepatocellular cancer].
Reinhardt M; Schulze M; Machnik G; Jorke D; Laske V; Krombholz B; Kappauf G; Schröder S
Dtsch Z Verdau Stoffwechselkr; 1987; 47(5):230-41. PubMed ID: 2449324
[TBL] [Abstract][Full Text] [Related]
8. [Acid glycosidases in leukocytes of patients with chronic and acute myeloid leukemias].
Minakova AL; Preobrazhenskaia ME; Khoroshko ND
Vopr Med Khim; 1986; 32(2):114-8. PubMed ID: 3010566
[TBL] [Abstract][Full Text] [Related]
9. [Total activity and distribution of multiple forms of lysosomal glycosidases in subfractions of human leukocytes].
Kuz'micheva NA; Vidershaĭn GIa
Vopr Med Khim; 1984; 30(5):76-81. PubMed ID: 6241372
[TBL] [Abstract][Full Text] [Related]
10. [Detection of alpha-fetoprotein-L3 using agglutinin-coupled spin column to be used in diagnosis of hepatocellular carcinoma].
Sun GZ; Zhao XY; Li JH; Zhao GQ; Wang SX; Kong SL
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(28):1986-8. PubMed ID: 19062741
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
12. Serum alpha-L-fucosidase activity and tumor size in hepatocellular carcinoma.
Takahashi H; Saibara T; Iwamura S; Tomita A; Maeda T; Onishi S; Yamamoto Y; Enzan H
Hepatology; 1994 Jun; 19(6):1414-7. PubMed ID: 7514563
[TBL] [Abstract][Full Text] [Related]
13. The effectiveness of serum alpha-fetoprotein level in anti-HCV positive patients for screening hepatocellular carcinoma.
Peng YC; Chan CS; Chen GH
Hepatogastroenterology; 1999; 46(30):3208-11. PubMed ID: 10626187
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of lens culinaris agglutinin-reactive alpha-fetoprotein in the diagnosis of hepatocellular carcinoma: evaluation in a Thai referral population.
Tanwandee T; Setthasin S; Charatcharoenwitthaya P; Chainuvati S; Leelakusolvong S; Pausawasdi N; Srikureja W; Pongprasobchai S; Manatsathit S; Kachintorn U; Ekpo P; Senawong S
J Med Assoc Thai; 2009 Mar; 92 Suppl 2():S49-56. PubMed ID: 19562986
[TBL] [Abstract][Full Text] [Related]
15. Combined serum hepatoma-specific alpha-fetoprotein and circulating alpha-fetoprotein-mRNA in diagnosis of hepatocellular carcinoma.
Wu W; Yao DF; Yuan YM; Fan JW; Lu XF; Li XH; Qiu LW; Zong L; Wu XH
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):538-44. PubMed ID: 17085339
[TBL] [Abstract][Full Text] [Related]
16. [Optimal cut-off value of PIVKA-II for diagnosis of hepatocellular carcinoma--using ROC curve].
Kim MJ; Bae KW; Seo PJ; Jeong IK; Kim JH; Lee BH; Bang KT; Kim DW; Song IH
Korean J Hepatol; 2006 Sep; 12(3):404-11. PubMed ID: 16998292
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of interleukin-6, interleukin-10 and human hepatocyte growth factor as tumor markers for hepatocellular carcinoma.
Hsia CY; Huo TI; Chiang SY; Lu MF; Sun CL; Wu JC; Lee PC; Chi CW; Lui WY; Lee SD
Eur J Surg Oncol; 2007 Mar; 33(2):208-12. PubMed ID: 17140760
[TBL] [Abstract][Full Text] [Related]
18. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
Wu C; Wang Z; Liu L; Zhao P; Wang W; Yao D; Shi B; Lu J; Liao P; Yang Y; Zhu L
J Gastroenterol Hepatol; 2009 Jan; 24(1):55-62. PubMed ID: 18823443
[TBL] [Abstract][Full Text] [Related]
19. [Detection of glycosidases in Pseudomonas of the fluorescent group: relation between serotype and glycosidase activities in P. aeruginosa].
Hansen W; Yourassowsky E
Ann Microbiol (Paris); 1983; 134B(3):411-9. PubMed ID: 6426362
[TBL] [Abstract][Full Text] [Related]
20. Serum alpha-mannosidase in patients with alcoholic liver disease.
Faber CN; Glew RH; Stanko RT
Enzyme; 1984; 31(1):1-10. PubMed ID: 6714194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
